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ABSTRACT
The mammalian clock and cell cycle are two essential biological
oscillators. In this work we investigate the coupling of these os-
cillators via non-linear dynamical modeling. We use previously
developed reduced models of these systems and study a molecular
interaction of MPF (mitosis promoting factor) repression by the
CLOCK:BMAL1 protein complex, via induction of the repressor
wee1. Furthermore, we propose an hypothesis whereby the clock
responds to cell cycle Growth Factors (GFs) via a pathway involv-
ing the non-essential cell cycle complex cyclin D/cdk4 and study
this interaction in the context of unidirectional clock→ cell cycle
coupling. We observe 1:1, 3:2, 4:3, 5:4 ratios of clock to cell cycle
period and identify GF and the coupling strength cb as decisive
control parameters for the system’s state of synchronization. Syn-
chronization ratios differing from 1:1, namely 3:2 and 5:4, have been
observed in cells treated with the corticosteroid Dexamethasone
(Dex). Here, we study Dex application and are able to reproduce the
induction of ratios differing from 1:1. Finally, because slowing down
the cell cycle is very relevant in the context of cancer therapies, we
devise particular protocols of cell cycle period control with the use
of clock inputs that are successful in substantially slowing down
the cell cycle by the use of the system’s synchronization dynamics,
obtaining 2:3, 3:4, 4:5 ratios of clock to cell cycle period.
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1 INTRODUCTION
The mammalian cell cycle and circadian clock are essential for
cellular health and homeostasis. The cell cycle includes cellular
growth and the division of a mother cell into two daughter cells
(mitosis) and is a key mechanism of cellular renewal and tissue
maintenance. The cellular circadian clock rhythmically controls
patterns of gene activation and protein expression with a 24 h
period, allowing the adaptation of cellular physiology to the daily
environmental changes. The circadian clock impacts the majority
of cellular genes and proteins, with genome-wide studies showing
a large proportion of drug targets to exhibit circadian patterns of
control [15]. As the mammalian clock and cell cycle often show
synchronized rhythms in healthy cells they may be considered
coupled oscillators.
Moreover, deregulation of any of these oscillators is linked to
disease. A crucial example of unregulated cell cycle is that of cer-
tain cancers, where mutations induce accelerated and uncontrolled
cellular division. In addition, deregulation of circadian rhythms
is linked to inflammation and insulin resistance [12]. This type
of deregulated systems presents evidence for the clock/cell cycle
interconnection as, for instance, cancer is associated with circadian
clock disturbances, inflammation and abnormal cellular metabolism
[17]. Moreover, timed drug delivery, or chronotherapy, maximizes
the desired drug effect while simultaneously minimizing undesired
side-effects [15].
Firstly, observations of clock/cell cycle interconnection have re-
vealed the entrainment of the cell cycle by the clock, for which some
molecular mechanisms have been established. These are the induc-
tion of the MPF repressor wee1 by the CLOCK:BMAL1 complex
[13], the regulation of the cell cycle inhibitor p21 by the clock com-
ponents REV-ERB-α /β and ROR-α /γ [9] and the clock-controlled
repression of c-Myc [7], which is a promoter of cell cycle progres-
sion via cyclin E induction [16]. Examples of models describing an
action of the clock on the cell cycle are Zámborszky et al., [22] and
Gérard and Goldbeter, [8]. In this work we study clock→ cell cycle
coupling by modeling the CLOCK:BMAL1-mediated repression of
MPF via wee1 induction.
More recently, however, evidence for a cell cycle action on the
clock has been revealed. Notably, Feillet et al., [5] and Bieler et
al., [4] have demonstrated in NIH3T3 mouse fibroblasts that the
frequency of both clock and cell cycle increases for various values
of % of FBS (Fetal Bovine Serum) in the medium. FBS contains
Growth Factors (GFs) that are a mixture of nutrients and hormones
known to accelerate the cell cycle. Observations reveal the clock to
accelerate in the same manner as the cell cycle, so that the periods
of both oscillators remain in a 1:1 ratio. Furthermore, the cell cycle
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mitotic event is verified to occur at a specific clock phase for all
cells [5]. This is consistent with a model of oscillators that are
phase-locked.
Phase locking (PL) is characterized by convergence of the com-
bined phase of oscillation ϕ(t) = (ϕ1(t),ϕ2(t)) to a closed curve –
an attractor. Phase-locked oscillators are synchronized through the
entire cycle – knowing the phase of one oscillator determines the
phase of the other, in ideal noise-free systems. The observations
of 1:1 phase-locking of clock and cell cycle ([4, 5]) have led to an
hypothesis of a mechanism of cell cycle action on the clock, i.e.
of the existence of bidirectional coupling between the oscillators.
Studies of molecular interactions of cell cycle → clock coupling
were made by Traynard et al., [18] and Almeida, [1]. By contrast, in
this work we propose a different hypothesis: that of a clock that is
responsive to Growth Factors (GFs). This is because unidirectional
coupling can be sufficient for 1:1 phase-lock and observations show
the increase of both clock and cell cycle frequencies with growth
factor. As such, we derive a term for the GF→ clock interaction,
that is based on an established molecular pathway of cyclinD/CDK4
and PGC1-α , [11].
Furthermore, Feillet et al., [5] observe that cells under the applica-
tion of a pulse of Dexamethasone exhibit different synchronization
ratios depending on the GF concentration. Dexamethasone (Dex) is
a glucocorticoid agonist known to synchronize the clocks of cell
populations. Synchronization ratios of clock to cell cycle periods in
Dex-treated cells were determined to be approximately 5:4 for 10%
FBS and 3:2 for 20% FBS. Additionally, for 20% FBS cells segregate in
two groups with the second one maintaining 1:1 synchronization.
In the same experiment a trimodal peak occurs for the distribution
of mitosis with circadian clock phase [5], an observation that has
also been made by Nagoshi et al., [14] under a similar protocol.
Almeida, [1] have reproduced such synchronization ratios in both
unidirectional cell cycle→ clock and bidirectional coupling, under
variation of different control parameters and when reproducing the
Dex-treatment protocol in silico.
In this work we investigate the dynamics of mammalian clock
and cell cycle coupling, using reduced dynamical models of both sys-
tems. The cell cycle model was developed and analyzed by Almeida
et al., [3] and in its most reduced form consists of a two variable
system forming a main negative regulatory loop between the essen-
tial cell cycle component MPF (mitosis promoting factor), which
is the cyclin B/CDK1 complex necessary and sufficient to carry
out the mitotic process, and its repressor the APC:cdc20 complex.
Furthermore, this model includes terms describing the action of
CDC25 phosphatase, an MPF activator, and the WEE1 kinase, an
MPF repressor. These terms are simplified as control loops of MPF
on itself, thus including the regulation MPF exerts in regulating
CDC25 and WEE1. This model yields relaxation oscillations and
shows regions of bistability of activeMPFwith the amount of cell cy-
cle GF [3]. The circadian clock model was developed by Almeida et
al., [2] and is based on the major transcription translation feedback
loop (TTFL) of the mammalian clock, where the protein complex
CLOCK:BMAL1 promotes the PER and CRY proteins that form
the PER:CRY complex, a repressor of CLOCK:BMAL1. This model
is centered on the regulation that occurs via three types of DNA
response elements within gene promoters: E-boxes, R-boxes and D-
boxes, and includes the effect of activators and repressors on these
boxes. It exhibits antiphasic oscillations between CLOCK:BMAL1
and PER:CRY, a characteristic of the mammalian circadian clock,
and it has been used to study the interconnection between clock
and metabolism [2]. In its reduced form, the clock model consists
of 4 variables: BMAL1, REV, DBP and PER:CRY and has already
been used by Almeida, [1] to study cell cycle→ clock coupling as
well as bidirectional coupling.
Ourwork aims at exploring strategies for cell cycle period control
in the context of unidirectional clock → cell cycle coupling. As
such, in Section 2 we study the entrainment of the cell cycle by the
clock via the knownmolecular interactionwhereby CLOCK:BMAL1
indirectly represses MPF (via the wee1 gene [13]). In Section 3 we
model and study the hypothesis of GF being not only a cell cycle
input but also acting on the circadian clock system. This mechanism
is explored in conjunction with the clock entrainment of the cell
cycle via wee1 induction and results in a dynamic behavior that
may help to explain the experimental observations of phase-locking
synchronization dynamics ([5]). In this work, we observe 1:1, 3:2,
4:3 and 5:4 clock to cell cycle period ratios and identify GF and the
coupling strength as decisive control parameters for the system’s
state of synchronization.
Moreover, we use the insight gained on the system’s synchroniza-
tion dynamics to explore strategies of period control. In particular,
we focus on slowing down the cell cycle – an idea that may be
of value for the control of cancer, which is characterized by a de-
regulated cell cycle. As such, we tune clock parameters and are
able to obtain higher periods of clock and cell cycle in 1:1 syn-
chronization as well as synchronization states with 2:3, 3:4 and 4:5
ratios of clock to cell cycle period, all cases consistent with a slower
cell cycle. Our period control protocols create an understanding of
multiple ways of slowing down the cell cycle, when making use of
the coupled system synchronization state dynamics. Throughout
the work, we observe the phase-locked oscillator, but focus mostly
on observing variations of clock to cell cycle periods ratios, i.e. on
the system’s period-lock (synchronization) state.
2 COUPLING VIA BMAL1-MEDIATEDWEE1
ACTIVATION
We start by establishing the basic dynamics of the unidirectional
clock→ cell cycle coupling. One notable mechanism is the induc-
tion of the wee1 gene by CLOCK:BMAL1 [13], as it involves the
variable BMAL1 present in the clock model to be used [2] as well
as the wee1 interaction with MPF that is included in the cell cycle
model [3]. Fig. 1 shows a scheme of the coupled system. Further-
more, Appendix A shows the equations of both models as well as
parameters.
The action of WEE1 on MPF is included in the term Vw ([3]),
which is now multiplied by the variable BMAL1 to represent the
effect of CLOCK:BMAL1 in promotingwee1 (and thus the repression
of MPF). The equation for MPF now becomes:
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Figure 1: Schematic of the clock→ cell cycle coupling mech-
anism. The CLOCK:BMAL1 protein complex (here the vari-
able BMAL1) repressesMPFactive due to its action in promot-
ing wee1 gene expression.
d[MPF ]
dt
=GF +Vc
MPFmax − [MPF ]
MPFmax − [MPF ] + kc
[MPF ]2
[MPF ]2 + k2m
− cb[BMAL1]Vw
[MPF ]
[MPF ] + kw
k2n
[MPF ]n + k2n
− γ1[APC : cdc20][MPF ]
(1)
where cb is the coupling strength parameter. Fig. 2 shows an
oscillatory solution of the main cell cycle variable MPF and the
main clock variable BMAL1. For GF = 10 and cb =10 the clock
entrains the cell cycle to its intrinsic period of 24 h. Because both
clock and cell cycle systems were previously normalized to a certain
concentration value [2] [3] , the solution of the coupled system is
dimensionless.
We will now observe how control parameters affect the synchro-
nization state. Fig. 3 shows the effect of GF on the synchronization
ratios for fixed cb = 10: for higher GF the ratio of clock to cell cycle
period (rT = TclockTcel l cycle ) tends to increase.
Furthermore, Table 1 shows the system’s period-lock response to
variation of the control parameter cb for fixedGF, which predicts the
appearance of 4:3 and 5:3 synchronization states; GF = 40 requires
a much higher value of cb for 1:1 synchronization than GF =20. For
GF = 20, the 4:3 and 1:1 period-lock ratios are obtained, while GF =
40 results in 5:3, 3:2 and 1:1 synchronization.
Moreover, in Fig. 4 the periods of both oscillators are shown for
cb = 10, for the same simulation as Fig. 3. Note that only the cell
cycle is responsive to GF. Thus, as expected for the clock→ cell
cycle unidirectional coupling, the period of the clock is kept at
24 h, while the period of the cell cycle is sped up. This results in
regions of a slower clock than cell cycle, which is in accordance
with experimental observations [5].
A question of interest is the possibility of tuning the period
of each oscillator by using the knowledge gained on the coupled
Figure 2: Oscillation of MPF and BMAL1. For GF = 10 and cb
=10 the system oscillates with a 24 h period.
Figure 3: GF controls the synchronization ratio of the cou-
pled system that increases with GF.
system. In particular, the ability of slowing down the cell cycle
using clock inputs is relevant for cancer treatment. From Fig. 4, this
may be achieved by either promoting a slower clock together with
coincidental period ratios (rT = 1) or hypothetically a faster clock
with rT > 1 so as to observe if an adaptation of the cell cycle period
occurs to a higher value (the opposite of what has been achieved
in Fig. 4).
2.1 Cell Cycle Period Control via the Clock
In order to explore cell cycle period control via clock inputs, we
focus on procedures that are experimentally feasible, such as single
parameter changes. These have the potential to be reproduced
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Table 1: cb controls the system’s synchronization ratio
GF = 20 GF = 40
cb rT cb rT
4 1.33 40 1.67
8 1.33 60 1.67
12 1.33 80 1.67
16 1.33 100 1.67
20 1.33 120 1.67
24 1.33 140 1.67
28 1.33 180 1.67
32 1.33 200 1.67
36 1.33 220 1.67
40 1.31 240 1.50
44 1.00 260 1.50
48 1.00 280 1.00
52 1.00 300 1.00
Figure 4: Circadian clock and cell cycle periods for cb = 10.
The period of the clock (blue squares) doesn’t change with
GF in the unidirectional coupling, while the period of the
cell cycle (red dots) adapts in a stepwise manner.
in experimental settings contingent upon the discovery of target
molecular compounds that specifically affect them. From Almeida
et al., [2] the parameters that affect clock period the most are those
of R-box (VR and kRr ) as well as the degradation rates of REV
and DBP (γr ev and γdb ). Thus, these are the best candidates for
synchronization control analysis.
We start by introducing the parameter α in the R-box equation
as: Rbox = VR
k2Rr
k2Rr+(α [REV ])2
. Here, α = 1 represents the original
system oscillating with the intrinsic period, while the parameter α
can either represent an R-box agonist (REV antagonist) for α < 1
or an R-box antagonist (REV agonist) for α > 1 by comparison
with the control state. This application is identical to rescaling the
parameter kRr → kRrα . Fig. 5 shows how α affects the period of
both oscillators and the ratio of clock to cell cycle period. When
α ≥ 1 the system is naturally entrained with a 1:1 period-lock and
increasingα increases the periods of both clock and cell cycle.When
α < 1 higher values of R-box expression and shorter clock period
are obtained resulting in a substantially increase in cell cycle period,
in accordance with our hypothesis. Thus, both slowing down and
speeding up the clock have the potential to slow down the cell cycle,
the first method works by maintaining a strong coupling between
the two oscillators and the second by accelerating the clock enough
to drive the system away from the 1:1 region causing the adaptation
of the cell cycle period.
Figure 5: Evolution of the oscillators’ period and synchro-
nization ratio with α . On top: values of α < 1 accelerate the
clock (blue) and for a region of small α the cell cycle (red)
“adapts” by slowing down, which makes the ratio between
the two periods smaller than 1 (bottom); for α ≥ 1 the sys-
tem synchronizes in a 1:1 manner and increasing the clock’s
period also increases that of the cell cycle. Overall, the 1:1,
1:2, 2:3, 3:4 and 4:5 ratios are obtained.
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Next, we observe period control via tuning of the REV and DBP
rates of natural degradation, γr ev and γbp . Some available com-
pounds are known to interfere with γr ev that could thus be used
for tuning this parameter. These drugs act mostly via inhibition of
GSk3β , known to increase phosphorylation of REV-ERB, and can
lead either to a decreased or increased clock period [19] depending
on the GSK-inhibitor used [10] [21]. We thus introduce β and δ as
modulators of these parameters as: γr ev → βγr ev andγdb → δγdb .
Fig. 6, shows a solution of the system with a combination of in-
creasedγr ev andγdb . In this case, β = 2 and δ = 1.5 leads to a much
slower cell cycle overall (T= 31.5 h) and a 1:3 period entrainment.
Figure 6: Oscillation of clock and cell cycle variables for
β = 2, δ = 1.5, GF = 10 and cb = 10. The system locks in a
1:3 ratio: Tclock = 10.5 h and Tcell cycle = 31.5 h. The cell cycle
is 3 times slower than the clock and overall slower than the
intrinsic coupled oscillators’ period (for β = 1 and δ = 1) of
24 h (see Fig. 2).
As we have focused on controlling the cell cycle because of its
relation to cancerous cell’s division rate, it is important to note that
healthy cells are likely to have same period clock and cell cycle
internal oscillators and the state of rT , 1 may be an indicator or
precursor of cellular disease [6]. This idea highlights the relevance
of the coupling strength parameter that promotes 1:1 synchroniza-
tion of clock and cell cycle. Thus, the experimental exploration of
chemical compounds for the tuning of this parameter would be of
relevance in this context.
3 COUPLING VIA GF-INDUCED INHIBITION
OF R-BOX
In this Section we propose a different additional mechanism for the
coupling of the mammalian clock and cell cycle. One of our goals is
to reproduce and understand the dynamical interactions behind the
phase-lock experimental observations of Feillet et al., [5] showing
that increasing amounts of GF speed up both the cell cycle and
the clock in a 1:1 synchronization state. So far, the hypothesis has
been that the cell cycle exerts influence on the clock and studies
have been performed on this assumption [1, 18]. Here, however we
study GF as a common input to both oscillators. Thus, instead of
assuming a coupling hypothesis where GF acts on the cell cycle that
in turn acts on the clock, we take a look at a pathway connecting
GF with the clock, such that GF is included in the model as a direct
clock input.
Growth factors promote expression of cyclin D, a non-essential
cell cycle cyclin that is active when in a complex with either CDK4
or CDK6, via β-catenin mediated pathways [20]. Despite cyclin D
being approximately constant during the cell cycle, its action during
the G1 phase precedes the activation of subsequent cyclin-CDK
complexes. However, because cyclin D is non-essential (its deletion
mutants still have a functioning cell cycle) and considering cells
can’t divide without GF, there must be other ways for GF to affect
the essential cell cycle elements, namely the cyclin B-CDK1 complex
(MPF). In the cell cycle model here used ([3]) MPF responds directly
to GF – an approximation that allows focusing on this exclusively
essential cell cycle species.
The cyclin D-CDK4 complex is known to negatively regulate
PGC1-α , by promoting its repressor GCN5 [11]. PGC1-α is an im-
portant clock component, with a role in promoting binding of ROR
to R-box. As such, we study the potential pathway connecting GF
to the clock: GF→ cyclinD-CDK4→ GCN5 —| PGC1-α . The effect
of GF as a repressor of R-box via the cyclin D/PGC1-α pathway can
be introduced by making the change VR → VR ksks+GF . R-box now
becomes:
Rbox = VR (
ks
ks +GF
) k
2
Rr
k2Rr + [REV ]2
(2)
The hypothesis introduced in Equation 2 raises the question of
whether or not a certain amount of GF is needed for clock oscilla-
tion, as cells in experimental settings usually require some growth
factor (often in the form of % of FBS) to be alive and functional.
Because the clock model has been built and calibrated based on the
established assumption of a cell autonomous clock, the removal of
GF (from Equation 2) doesn’t affect clock oscillations. Nevertheless,
if that were to be the case, this could be achieved by adjusting the
parameter VR to a higher value, incompatible with oscillations at
GF = 0, and then modulate VR by the presence of GF (see Equation
2). However, for simplicity, we will assume GF as a clock input
that can control its period but it’s still not required for oscillation.
This modeling implies that GF = 0 yields the 24 h intrinsic clock
oscillation that has been the basis of our clock studies so far.
We verify that with this model, clock oscillations are maintained
in the entire GF region of cell cycle oscillation (4 ≤ GF ≤ 80) and as
GF increases the period of the circadian clock decreases. Thus, GF
has a similar speeding up effect in both the clock and the cell cycle,
which is in agreement with observations [5]. A schematic of the
coupled system that includes the established interaction of BMAL1
repression of MPF via wee1 is shown in Fig. 7. The unidirectional
clock→ cell cycle coupling introduced in the previous section is
maintained and GF is now a common input.
We start by analyzing the effect of GF on the oscillators’ syn-
chronization state for two values of cb with and without a Dexam-
ethasone input. Fig. 8 (top) shows that for cb = 10 a region of 1:1
period-lock is followed by a region where the ratio of clock to cell
cycle period increases up to a value of 1.3. This synchronization
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Figure 7: Schematic of the GF-responsive clock system cou-
pled by the BMAL1 repression of active MPF (via the wee1
pathway). GF controls both the cell cycle and the clock. The
hypothesis is that GF represses R-box (at the BMAL1 pro-
moter) via the cyclin D-CDK4/PGC1α pathway.
ratio adequately compares with the experimental observations of
Feillet et al., [5]. By contrast, cb = 50 results in a wider region of 1:1
period-lock. Moreover, a Dex additive input on the PER equation
(see Equation 6 of Appendix A) alters the system’s behavior. In
particular, for cb = 10 the 1:1 synchronization region becomes nar-
rower with the point of synchronization state change being shifted
to a lower value of GF (Fig. 8 (bottom)). This “shift to the left” effect
is similar to that observed for Dex application in unidirectional cell
cycle→ clock and bidirectional coupling studied by Almeida, [1]
and evidences a GF region where the presence of Dex drives the
system away from the 1:1 synchronization state (an example would
be GF = 20, with cb = 10). Thus, assuming GF as a clock input in
conjunction with the unidirectional clock→ cell cycle coupling is
also successful in reproducing experimental observations and may
provide a complementary explanation for the coupled oscillators’
behavior to that of a cell cycle direct action on the clock.
Moreover, we investigate the local maximum of rT in the region
that follows the 1:1 synchronization (Fig. 8). On Table 2 we observe
the maximum rT value for 4 ≤ GF ≤ 45 for different values of cb
with and without Dex. Without Dex, synchronization ratios vary
between 5:4 and 4:3, specifically 1.3 for cb = 10, 4:3 for cb = 20
and cb = 30 and 5:4 for cb = 40. The presence of Dex lowers the
maximum rT value of the system.
Additionally, Fig. 9 shows the period of the system as GF varies,
for cb = 10 with no Dex. Differently from Fig. 4, the period of the
clock is now responsive to GF. Nevertheless, observe that the GF
region where the ratio between periods is kept close to a constant
results from the adaptation of the cell cycle period to that of the
clock, as expected for the unidirectional clock→ cell cycle coupling.
Thus, similarly to Section 2, this raises the question of the possibility
of cell cycle period control via clock tuning.
Figure 8: Variation of the synchronization ratio with GF for
two values of cb with Dex = 0 and Dex = 5.
Table 2: Maximum synchronization ratio with cb for
4 ≤ GF ≤ 45, with Dex = 0 and Dex = 5.
cb Dex = 0 Dex = 5
10 1.30 1.28
20 1.33 1.29
30 1.33 1.25
40 1.25 1.18
We test this possibility by making γr ev → βγr ev , as above, and
varying β for values around 1, see Fig. 10. In this case, we can
vary 0.6 ≤ β ≤ 2.5 and observe that slowing down the clock by
decreasing β effectively slows down the cell cycle while maintaining
1:1 synchronization. For 1 < β < 1.4 we observe that speeding up
the clock results in a sped up cell cycle, as the oscillators maintain
the 1:1 synchronization, and for β ≥ 1.4 the system breaks out of
the 1:1 synchronization state and states of rT < 1 appear again,
where the cell cycle is slower than the clock. Thus, tuning the
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parameter γr ev is also successful in cell cycle period control in the
unidirectional clock to cell cycle coupling with a GF-responsive
circadian clock.
Figure 9: Periods of the GF-responsive clock and cell cycle
as GF varies for cb = 10 and Dex = 0.
Figure 10: Variation of the GF-responsive clock and cell cy-
cle periods with β . Slowing down the cell cycle is possible
either by slowing down the clock, which maintains the 1:1
synchronization, or by speeding up the clock enough so as to
cause the adaptation of the synchronization ratio to rT < 1 ,
resulting in a slowing down of the cell cycle by comparison
with the control (with β = 1).
In general, the hypothesis of a GF-responsive clock here pro-
posed adds another layer of complexity to the coupling problem, as
there isn’t yet a way of knowing how relevant to circadian rhythms
the effect of GF-transducing pathways is versus the effect of the
cell cycle and whether this is influenced by the cellular (and extra-
cellular) context (metabolism, signaling). In particular, the pathway
proposed by us on Section 3 could be tested via knock-out experi-
ments of the intermediary components cyclin D/CDK4 and GCN5.
Moreover, experimental observations where GF is varied in a large
interval with andwithout Dex (or other period tuning inputs) would
allow comparison with our simulations and to understand which
interactions are more relevant for the behavior of the system.
4 CONCLUSIONS
In this work we have studied unidirectional clock→ cell cycle
coupling centered on the observed CLOCK:BMAL1-induced wee1
activation, which was modeled as an MPF repression. Furthermore,
we have modeled this interaction together with a GF action on the
clock via a pathway involving the non-essential cell cycle complex
cyclin D/CDK4. In both cases we have obtained ratios of clock to cell
cycle periods compatible with experimental observations [5] and
observed dynamical behavior under changes in coupling strength
and GF. Furthermore, Dex application in the unidirectional clock
→ cell cycle coupling with a clock that is responsive to GF results
in inducing rT > 1, also in accordance with observations [5].
From a biological a biological point of view, an exclusively uni-
directional clock→ cell cycle coupling mechanism implies that
in order to obtain experimental synchronization ratios of acceler-
ating clock and cell cycle with increasing GF, there needs to be a
GF responsive clock. A bidirectional coupling on the other hand
requires simultaneous modeling of both clock→ cell cycle and
cell cycle→ clock molecular interactions, which raises questions
from the modeling point of view as the latter hasn’t been estab-
lished. Almeida, [1] propose an action of MPF in phosphorylating
an essential clock component, an hypothesis that also yields syn-
chronization ratios comparable to experimental observations.
Moreover, we have explored cell cycle period control, with rel-
evance for cancer growth control, by means of single-parameter
changes in the clock system. We have found that it is possible to
slow down the cell cycle by either slowing down the clock when
promoting a state of 1:1 synchronization, or by speeding up the
clock sufficiently so as to generate a state where the cell cycle
adapts by slowing down maintaining a rational synchronization
ratio. The methods here developed may form a basis for the creation
of experimental protocols to test the synchronization dynamics of
these oscillators.
A MAMMALIAN CLOCK AND CELL CYCLE
MODELS
In this work we study the coupling of the mammalian cell cycle
model developed by Almeida et al., [3] with the mammalian circa-
dian clock model developed by Almeida et al., [2] and Almeida, [1].
The model equations are summarized here:
d[BMAL1]
dt
= Rbox − γbp [BMAL1][PER : CRY ] (3)
d[DBP]
dt
= VB [BMAL1] − γdb [DBP] (4)
d[REV ]
dt
= VD2[DBP] − γr ev [REV ] (5)
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d[PER : CRY ]
dt
= Dex +VD2[DBP]−γbp [BMAL1][PER : CRY ] (6)
d[MPF ]
dt
=GF +Vc
MPFmax − [MPF ]
MPFmax − [MPF ] + kc
[MPF ]2
[MPF ]2 + k2m
−Vw [MPF ][MPF ] + kw
k2n
[MPF ]n + k2n
− γ1[APC : cdc20][MPF ]
(7)
d[APC : cdc20]
dt
= Vm [MPF ] −Vk [APC : cdc20] (8)
where
Rbox = VR
k2Rr
k2Rr + [REV ]2
(9)
and the parameter GF represents an MPF synthesis term due to
the presence of Growth Factor. BMAL1 represents the CLOCK:BMAL1
complex, REV all REV-ERBs and DBP all D-box activators. Parame-
ters for all simulations are in Table 3 and we use the initial condi-
tion: BMAL = 1.2; DBP = 1.6; REV = 1.5; PER:CRY = 1.2; MPF = 2.0;
APC:cdc20 = 1.0. The Dex additive input to PER:CRY represents the
hormone Dexamethasone and is used only once in Section 3, being
kept at zero for the remaining studies.
Table 3: Parameters of the clock and cell cycle models
p Numerical Value
VR 34.4 h−1
kRr 80.1
VB 0.11 h−1
VD2 14.7 h−1
γr ev 0.187 h−1
γdb 0.121 h−1
γbp 2.0 h
γ1 0.162 h−1
Vc 2260 h−1
kc 130
Vw 7480 h−1
kw 138
km 99
kn 0.116
Vm 1.68 h−1
Vk 1.07 h−1
MPFmax 284
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